(Q34706680)

4 August 2017

1 reference

title

Molecular basis of buspirone's anxiolytic action (English)

1 reference

4 August 2017

Molecular Basis of Buspirone's Anxiolytic Action (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

28 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

28 November 2022

author name string

G. Tunnicliff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796057

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1796057

28 November 2022

publication date

1 September 1991

1 reference

full work available at URL

4 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0773.1991.tb01289.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1991.tb01289.x/fullpdf

28 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Basic and Clinical Pharmacology and Toxicology

28 November 2022

published in

1 reference

4 August 2017

69

1 reference

4 August 2017

149-156

1 reference

4 August 2017

3

1 reference

Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1991.TB01289.X

Effect of diazepam on plasma corticosterone levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1991.TB01289.X

Monoaminergic involvement in the pharmacological actions of buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1991.TB01289.X

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1991.TB01289.X

Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Quantitative autoradiographic distribution and pharmacological characterization of (3H)buspirone binding to sections from rat, bovine and marmoset brain

28 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.

28 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Neuroendocrine effects of buspirone in patients with generalized anxiety disorder

28 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Pharmacological effects of GABA on serotonin metabolism in the rat brain.

28 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

28 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors

28 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone: Action on serotonin receptors in calf hippocampus

28 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone enhances benzodiazepine receptor binding in vivo

28 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Metergoline abolishes the prolactin response to buspirone

28 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings

28 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Mechanism of Action of Barbiturates

28 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

An animal behavior model for studying central serotonergic synapses

28 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Autoradiographic localization of [3H]buspirone binding sites in rat brain

28 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone

28 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Reduction by two benzodiazepines and pentobarbitone of the multiunit activity in substantia nigra, hippocampus, nucleus locus coeruleus and nucleus raphé dorsalis of encéphale isolé rats.

28 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Modulation of the electrically evoked release of 5-[3H]hydroxytryptamine from rat cerebral cortex: effects of alpidem, CL 218872, and diazepam.

28 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in rat.

28 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission

28 November 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug

28 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Dopamine receptor antagonism by the novel antianxiety drug, buspirone

28 November 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Comparative effects of clozapine and α-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain

28 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

The effect of buspirone on prolactin and growth hormone secretion in man

28 November 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Stimulation of rat prolactin secretion by indolealkylamine hallucinogens

28 November 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover

28 November 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat

28 November 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone enhances [3H]flunitrazepam binding in vivo

28 November 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Serotonergic involvement in the inhibitory effects of repeated buspirone treatment on synaptic transmission in the hippocampus

28 November 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Drug interactions at the GABA receptor-ionophore complex

28 November 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo

28 November 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.

28 November 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

5-Hydroxytryptamine receptor subtypes

28 November 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Serotonergic anxiolytics and treatment of depression

28 November 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Neurophysiological effects of buspirone and isapirone in the hippocampus: comparison with 5-hydroxytryptamine.

28 November 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Review important concepts of receptor theory

28 November 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity

28 November 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

28 November 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

28 November 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.

28 November 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain.

28 November 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

Buspirone: A potential atypical neuroleptic

28 November 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1991.TB01289.X

28 November 2022

Identifiers

1 reference

4 August 2017

1 reference